JANE STREET GROUP, LLC - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 126 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$176,271
-52.6%
10,148
-61.6%
0.00%
Q2 2023$371,980
+158.3%
26,419
+136.0%
0.00%
Q3 2022$144,000
-63.6%
11,194
-72.6%
0.00%
Q2 2022$396,000
-45.3%
40,859
-43.8%
0.00%
Q1 2022$724,000
-19.7%
72,731
-5.2%
0.00%
Q4 2021$902,000
+127.8%
76,700
+120.3%
0.00%
Q3 2021$396,000
+144.4%
34,821
+228.5%
0.00%
Q3 2020$162,00010,5990.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,025,000$12,064,0002.56%
GREAT POINT PARTNERS LLC 536,738$6,317,0001.40%
Endurant Capital Management LP 244,125$2,873,0000.69%
HHLR ADVISORS, LTD. 2,920,023$34,369,0000.53%
Integral Health Asset Management, LLC 140,000$1,648,0000.46%
Spearhead Capital Advisors, LLC 235,024$2,766,0000.33%
Jackson Creek Investment Advisors LLC 77,069$907,0000.32%
RICE HALL JAMES & ASSOCIATES, LLC 712,807$8,390,0000.30%
Parkman Healthcare Partners LLC 113,644$1,338,0000.30%
Birchview Capital, LP 30,000$353,0000.23%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders